Aurora Cannabis Inc Net Assets

Latest as of June 2026: CA$527.13 Million CAD ≈ $381.32 Million USD

Aurora Cannabis Inc net assets. Based on the latest financial reports, Aurora Cannabis Inc (ACB) has net assets worth CA$527.13 Million CAD (≈ $381.32 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$620.88 Million ≈ $449.13 Million USD) and total liabilities (CA$93.75 Million ≈ $67.81 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore ACB year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric Value
Current Net Assets CA$527.13 Million
% of Total Assets 84.9%
Annual Growth Rate 45.16%
5-Year Change -22.73%
10-Year Change 133.78%
Growth Volatility 798.38

Net Assets of Aurora Cannabis Inc (2007–2026)

Net assets of Aurora Cannabis Inc from 2007 to 2026. This chart illustrates how Aurora Cannabis Inc's net assets have evolved over time, based on quarterly financial data. See Aurora Cannabis Inc (ACB) net asset quality to measure how much of total assets are equity-financed.

Annual Net Assets for Aurora Cannabis Inc (2007–2026)

The table below shows the annual net assets of Aurora Cannabis Inc from 2007 to 2026. For live market cap and overall valuation, see how much is Aurora Cannabis Inc worth.

Year Net Assets Change
2026-03-31 CA$511.83 Million
≈ $370.25 Million
-15.90%
2025-03-31 CA$608.59 Million
≈ $440.25 Million
+1.12%
2024-03-31 CA$601.87 Million
≈ $435.38 Million
+16.39%
2023-03-31 CA$517.14 Million
≈ $374.09 Million
-21.92%
2022-03-31 CA$662.35 Million
≈ $479.14 Million
-67.50%
2021-03-31 CA$2.04 Billion
≈ $1.47 Billion
-4.17%
2020-03-31 CA$2.13 Billion
≈ $1.54 Billion
-51.56%
2019-03-31 CA$4.39 Billion
≈ $3.18 Billion
+180.85%
2018-03-31 CA$1.56 Billion
≈ $1.13 Billion
+613.98%
2017-03-31 CA$218.93 Million
≈ $158.37 Million
+3572.04%
2016-03-31 CA$5.96 Million
≈ $4.31 Million
+55.56%
2015-03-31 CA$3.83 Million
≈ $2.77 Million
+183.21%
2014-03-31 CA$1.35 Million
≈ $979.00K
+94.95%
2013-03-31 CA$694.20K
≈ $502.17K
-35.40%
2012-03-31 CA$1.07 Million
≈ $777.31K
-21.72%
2011-03-31 CA$1.37 Million
≈ $992.94K
-19.93%
2010-03-31 CA$1.71 Million
≈ $1.24 Million
+5.88%
2009-03-31 CA$1.62 Million
≈ $1.17 Million
-3.93%
2008-03-31 CA$1.69 Million
≈ $1.22 Million
+291.72%
2007-03-31 CA$430.22K
≈ $311.22K
--

Equity Component Analysis

This analysis shows how different components contribute to Aurora Cannabis Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 508437984.8% over the analyzed period, potentially due to dividend distributions or operating losses.

Aurora Cannabis Inc Net Assets Breakdown (March 2026)

Aurora Cannabis Inc net assets breakdown by equity component as of March 2026.

Component Amount Percentage
Common Stock CA$7.01 Billion 1369.05%
Other Comprehensive Income CA$-213.59 Million -41.73%
Other Components CA$160.11 Million 31.28%
Total Equity CA$511.83 Million 100.00%

Aurora Cannabis Inc Competitors by Market Cap

The table below lists competitors of Aurora Cannabis Inc ranked by their market capitalization.

Company Market Cap
AVCON Information Tech
SHE:300074
$259.34 Million
Asuransi Tugu Pratama Indonesia Tbk PT
JK:TUGU
$259.39 Million
Guangdong Kitech New Material Holding Co.Ltd.
SHE:300995
$259.44 Million
Sinomach General Machinery Science Technology Co Ltd
SHG:600444
$259.47 Million
Nivika Fastigheter AB Series B
ST:NIVI-B
$259.17 Million
Transcom Inc
TW:5222
$259.16 Million
Federal-Mogul Goetze (India) Limited.
NSE:FMGOETZE
$259.13 Million
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
$259.04 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Aurora Cannabis Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2025 to 2026, total equity changed from 567,171,000 to 511,832,000, a change of -55,339,000 (-9.8%).
  • Net loss of 121,760,000 reduced equity.
  • New share issuances of 10,906,000 increased equity.
  • Other comprehensive income decreased equity by 157,356,000.
  • Other factors increased equity by 212,871,000.

Equity Change Factors (2025 to 2026)

Factor Impact Contribution
Net Income CA$-121.76 Million -23.79%
Share Issuances CA$10.91 Million +2.13%
Other Comprehensive Income CA$-157.36 Million -30.74%
Other Changes CA$212.87 Million +41.59%
Total Change CA$- -9.76%

Book Value vs Market Value Analysis

This analysis compares Aurora Cannabis Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.63x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has increased from 0.21x to 0.63x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2007-03-31 CA$26.42 CA$5.66 x
2008-03-31 CA$18.02 CA$5.66 x
2009-03-31 CA$13.49 CA$5.66 x
2010-03-31 CA$13.91 CA$5.66 x
2011-03-31 CA$10.37 CA$5.66 x
2012-03-31 CA$8.11 CA$5.66 x
2013-03-31 CA$5.20 CA$5.66 x
2014-03-31 CA$10.06 CA$5.66 x
2015-03-31 CA$0.60 CA$5.66 x
2016-03-31 CA$5.55 CA$5.66 x
2017-03-31 CA$94.15 CA$5.66 x
2018-03-31 CA$396.80 CA$5.66 x
2019-03-31 CA$547.36 CA$5.66 x
2020-03-31 CA$222.30 CA$5.66 x
2021-03-31 CA$120.49 CA$5.66 x
2022-03-31 CA$30.80 CA$5.66 x
2023-03-31 CA$15.06 CA$5.66 x
2024-03-31 CA$10.92 CA$5.66 x
2025-03-31 CA$10.17 CA$5.66 x
2026-03-31 CA$9.02 CA$5.66 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Aurora Cannabis Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -23.79%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -37.98%
  • • Asset Turnover: 0.53x
  • • Equity Multiplier: 1.17x
  • Recent ROE (-23.79%) is above the historical average (-52.49%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2007 0.29% 0.00% 0.00x 1.03x CA$-41.76K
2008 -10.52% -340.87% 0.03x 1.00x CA$-345.81K
2009 -9.00% -356.71% 0.03x 1.01x CA$-307.57K
2010 -2.56% 0.00% 0.00x 1.01x CA$-215.33K
2011 -23.49% 0.00% 0.00x 1.01x CA$-459.76K
2012 -29.39% 0.00% 0.00x 1.04x CA$-423.22K
2013 -56.68% 0.00% 0.00x 1.04x CA$-462.91K
2014 -29.53% 0.00% 0.00x 1.39x CA$-535.04K
2015 -248.34% 0.00% 0.00x 3.53x CA$-9.90 Million
2016 -95.99% -397.71% 0.08x 3.09x CA$-6.32 Million
2017 -5.92% -71.78% 0.06x 1.47x CA$-34.86 Million
2018 4.62% 130.33% 0.03x 1.23x CA$-83.92 Million
2019 -6.69% -119.54% 0.04x 1.25x CA$-732.07 Million
2020 -152.63% -1221.68% 0.10x 1.29x CA$-3.50 Billion
2021 -34.04% -282.82% 0.09x 1.28x CA$-897.39 Million
2022 -259.52% -776.02% 0.20x 1.64x CA$-1.78 Billion
2023 -54.59% -113.73% 0.25x 1.91x CA$-313.94 Million
2024 -12.38% -25.65% 0.32x 1.50x CA$-125.30 Million
2025 0.28% 0.46% 0.40x 1.50x CA$-55.13 Million
2026 -23.79% -37.98% 0.53x 1.17x CA$-172.94 Million

Industry Comparison

This section compares Aurora Cannabis Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $248,878,772
  • Average return on equity (ROE) among peers: -90.14%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Aurora Cannabis Inc (ACB) CA$527.13 Million 0.29% 0.18x $259.21 Million
Amotiv Limited (AOV) $795.11 Million 0.54% 0.21x $576.83 Million
Aequus Pharmaceuticals Inc (AQS) $-4.29 Million 0.00% 0.00x $479.73K
Avicanna Inc (AVCN) $3.46 Million -426.03% 4.09x $10.21 Million
Avant Brands Inc (AVNT) $-490.96K 0.00% 0.00x $5.58 Million
Bausch Health Companies Inc (BHC) $1.30 Billion 15.07% 0.37x $3.10 Billion
CanadaBis Capital Inc (CANB) $455.59K -35.67% 0.03x $1.53 Million
Cannabist Company Holdings Inc (CBST) $65.35 Million -268.87% 11.60x $12.41 Million
Cipher Pharmaceuticals Inc (CPH) $54.26 Million 3.26% 1.02x $239.92 Million
Cardiol Therapeutics Inc Class A (CRDL) $28.25 Million -99.58% 0.30x $130.88 Million

About Aurora Cannabis Inc

TO:ACB Canada Drug Manufacturers - Specialty & Generic
Market Cap
$259.21 Million
CA$358.33 Million CAD
Market Cap Rank
#15257 Global
#453 in Canada
Share Price
CA$5.66
Change (1 day)
-1.39%
52-Week Range
CA$3.64 - CA$7.71
All Time High
CA$1808.40
About

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis… Read more